Corcept Therapeutics Incorporated Operating Cash Flow 2011-2026 | CORT

Annual Operating Cash Flow Corcept Therapeutics Incorporated

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
142 M	198 M	127 M	120 M	168 M	152 M	136 M	116 M	60.9 M	18.4 M	-	-	-37.1 M	-36 M	-27.4 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
198 M	-37.1 M	87.5 M

Quarterly Operating Cash Flow Corcept Therapeutics Incorporated

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	5.13 M	-	-	23.8 M	-	-	26 M	-	86.9 M	-	35.2 M	-	118 M	-	25.4 M	-	117 M	86.5 M	33.3 M	-	87.7 M	49.2 M	23.7 M	-	94.1 M	49.6 M	34.4 M	-	36.1 M	25.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-11.6 M	-	-27.3 M	-18 M	-10.2 M	-	-21.1 M	-14.5 M	-7.3 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
118 M	-27.3 M	33.9 M

Operating Cash Flow of other stocks in the Biotechnology industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-481 M	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	-14 M	-	-24.86 %	$ 820 K	USA
Burford Capital Limited BUR	181 M	$ 4.73	0.42 %	$ 761 M	Britain
Adverum Biotechnologies ADVM	-92.5 M	-	-	$ 86.2 M	USA
Cabaletta Bio CABA	-131 M	$ 3.4	4.29 %	$ 342 M	USA
Alnylam Pharmaceuticals ALNY	524 M	$ 333.39	-1.77 %	$ 43.7 B	USA
Can-Fite BioPharma Ltd. CANF	-8.95 M	$ 3.17	3.93 %	$ 5.22 M	Israel
I-Mab IMAB	-1.3 B	-	-	$ 866 M	China
Alterity Therapeutics Limited ATHE	-12.3 M	$ 3.73	3.04 %	$ 8.97 B	Australia
AlloVir ALVR	-38.4 M	-	4.14 %	$ 49.1 M	USA
Genfit SA GNFT	99.9 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-23.8 M	-	-13.47 %	$ 169 M	France
Aligos Therapeutics ALGS	-82.5 M	$ 7.42	-15.1 %	$ 73.3 M	USA
Allakos ALLK	-116 M	-	-	$ 28.6 M	USA
Applied Molecular Transport AMTI	-93.9 M	-	-	$ 10.1 M	USA
Midatech Pharma plc MTP	-6.01 M	-	-18.52 %	$ 27.3 M	Britain
Applied Therapeutics APLT	-55.2 M	-	-	$ 8.42 M	USA
Aptinyx APTX	-59.7 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	-65.1 M	-	-13.39 %	$ 1.45 M	USA
Amphastar Pharmaceuticals AMPH	156 M	$ 21.68	1.4 %	$ 1.01 B	USA
BioNTech SE BNTX	890 M	$ 99.47	1.08 %	$ 27.2 B	Germany
Advaxis ADXS	-29.5 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-8.58 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-18 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-169 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	68 M	-	-	$ 399 M	USA
Applied Genetic Technologies Corporation AGTC	-65.7 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	-52.4 M	$ 4.24	2.17 %	$ 453 M	USA
Arcutis Biotherapeutics ARQT	-5.62 M	$ 24.58	-2.03 %	$ 3.13 B	USA
Brainstorm Cell Therapeutics BCLI	-6.98 M	-	-2.5 %	$ 5.88 M	USA
AIkido Pharma AIKI	22.7 M	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	41 M	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	-284 M	$ 1.49	0.68 %	$ 397 M	Britain
Aptose Biosciences APTO	-22 M	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	1.13 B	-	0.49 %	$ 251 B	Cayman-islands
AVROBIO AVRO	-63.2 M	-	1083.1 %	$ 745 M	USA
CNS Pharmaceuticals CNSP	-13.8 M	$ 2.75	4.16 %	$ 1.22 M	USA
Ayala Pharmaceuticals AYLA	-34.5 M	-	-	$ 7.46 M	Israel
bluebird bio BLUE	-235 M	-	-	$ 546 M	USA
AstraZeneca PLC AZN	5.96 B	-	-	$ 96.9 B	Britain
Akero Therapeutics AKRO	-230 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	-733 M	-	-	$ 867 M	Germany
Cidara Therapeutics CDTX	-177 M	-	-	$ 1.41 B	USA
Akari Therapeutics, Plc AKTX	-10.6 M	-	-	$ 310 B	Britain
Akouos AKUS	-63.7 M	-	0.23 %	$ 488 M	USA
Allena Pharmaceuticals ALNA	-45.7 M	-	3.16 %	$ 1.9 M	USA
Esperion Therapeutics ESPR	-13.1 M	$ 2.17	5.85 %	$ 451 M	USA